Insider · CIK 0001830001

Wolfe Josh

Reports to the SEC for 8 companies · MILLBRAE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001830001

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-06	EIKNEikon Therapeutics, Inc. · Series D Preferred StockC Conversion	Director, 10% Owner	CConversion	−10.3M sh	—	—	0
2026-02-06	EIKNEikon Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+2.39M sh	—	—	2,387,705
2026-02-06	EIKNEikon Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+1.15M sh	—	—	1,290,428
2026-02-06	EIKNEikon Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+2.16M sh	—	—	2,294,653
2026-02-06	EIKNEikon Therapeutics, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−10M sh	—	—	0
2026-02-06	EIKNEikon Therapeutics, Inc. · Series A-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−7.81M sh	—	—	0
2026-02-06	EIKNEikon Therapeutics, Inc. · Series A-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.5M sh	—	—	0
2026-02-06	EIKNEikon Therapeutics, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−796K sh	—	—	0
2026-02-06	EIKNEikon Therapeutics, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−531K sh	—	—	0
2026-02-06	EIKNEikon Therapeutics, Inc. · Series B-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−5.29M sh	—	—	0
2026-02-06	EIKNEikon Therapeutics, Inc. · Series B-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−3.53M sh	—	—	0
2026-02-06	EIKNEikon Therapeutics, Inc. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−303K sh	—	—	0
2026-02-06	EIKNEikon Therapeutics, Inc. · Series C-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.45M sh	—	—	0
2026-02-04	EIKNEikon Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+139K sh	$18.00	+$2.5M	138,888
2026-02-04	EIKNEikon Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+139K sh	$18.00	+$2.5M	138,888
2023-06-15	Shapeways Holdings, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+62.5K sh	—	—	62,500
2022-06-08	Shapeways Holdings, Inc.A Award	Director, 10% Owner	AAward	+31.3K sh	—	—	31,250
2021-09-29	Shapeways Holdings, Inc.A Award	Director, 10% Owner	AAward	+155K sh	—	—	155,400
2021-09-29	Shapeways Holdings, Inc.A Award	Director, 10% Owner	AAward	+17.3K sh	—	—	17,267
2021-09-29	Shapeways Holdings, Inc.A Award	Director, 10% Owner	AAward	+3.43M sh	—	—	3,430,000
2021-09-29	Shapeways Holdings, Inc.A Award	Director, 10% Owner	AAward	+181 sh	—	—	181
2021-09-29	Shapeways Holdings, Inc.A Award	Director, 10% Owner	AAward	+300K sh	$10.00	+$3M	300,000
2021-09-29	Shapeways Holdings, Inc.A Award	Director, 10% Owner	AAward	+1,633 sh	—	—	1,633
2021-09-29	Shapeways Holdings, Inc.A Award	Director, 10% Owner	AAward	+381K sh	—	—	381,111
2021-09-29	Shapeways Holdings, Inc.A Award	Director, 10% Owner	AAward	+2.56M sh	—	—	2,563,614
2021-09-29	Shapeways Holdings, Inc.A Award	Director, 10% Owner	AAward	+285K sh	—	—	284,846

Recent filings

Accepted (ET)
Feb 64
Wolfe Josh0001193125-26-041549
SEC(opens sec.gov)
Jun 204
Wolfe Josh0001628280-23-022696
SEC(opens sec.gov)
Jun 104
Wolfe Josh0001628280-22-016759
SEC(opens sec.gov)
Oct 14
Wolfe Josh0001104659-21-122225
SEC(opens sec.gov)

Companies

Address

C/O EIKON THERAPEUTICS 230 HARRIET TUBMAN WAY

MILLBRAE, CA, 94030